Shelly Menolascino MD
Washington Square Psychiatry & TMS
On-Site Psychiatrist Supervision of All TMS Treatments
By Dr. Menolascino
Over 18,000 Treatments Performed Since 2013
TMS and Neuromodulation:
-
Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. 2012 Carpenter LL1, Janicak PG, Aaronson ST, Boyadjis T, Brock DG, Cook IA, Dunner DL, Lanocha K, Solvason HB, Demitrack MA.
-
A Multisite, Naturalistic, Observational Study of Transcranial Magnetic Stimulation for Patients With Pharmacoresistant Major Depressive Disorder. 2014 David L. Dunner, MD; Scott T. Aaronson, MD; Harold A. Sackeim, PhD; Philip G. Janicak, MD; Linda L. Carpenter, MD; Terrence Boyadjis, MD; David G. Brock, MD; Dafna Bonneh-Barkay, PhD; Ian A. Cook, MD; Karl Lanocha, MD; H. Brent Solvason, MD, PhD; and Mark A. Demitrack, MD
-
Effectiveness of transcranial magnetic stimulation (TMS) in clinical practice post-FDA approval in the United States: results observed with the first 100 consecutive cases of depression at an academic medical center. 2012 Connolly KR1, Helmer A, Cristancho MA, Cristancho P, O'Reardon JP.
-
The expanding evidence base for TMS treatment of depression 2013 Mark S. George, Joseph J. Taylor, and E. Baron Short
-
Neuromodulation for treatment-resistant depression. Holtzheimer 2012 Paul E. Holtzheimer and Helen S. Mayberg F1000 medicine reports 4 (2012).
Online and Journals:
On Depression:
-
Where in the Brain Is Depression? 2012 Mayur Pandya, Murat Altinay, Donald A. Malone Jr., Amit Anand
-
Major Depression Among Adults: NiMH National Institute of Mental Health
-
National Institute of Mental Health. US Department of Health and Human Services. Depression.
Neuroscience and Therapy:
Genetic Insights:
-
Psychiatry as a Clinical Neuroscience Discipline Insel, Thomas R., and Remi Quirion. "Psychiatry as a clinical neuroscience discipline." Jama 294.17 (2005): 2221-2224.
-
A Naturalistic Study of the Effectiveness of Pharmacogenetic Testing to Guide Treatment in Psychiatric Patients With Mood and Anxiety Disorders 2015 Francis X. Brennan, PhD; Kathryn R. Gardner, MS; Jay Lombard, DO; Roy H. Perlis, MD, MSc; Maurizio Fava, MD; Herbert W. Harris, MD, PhD; and Rachel Scott, PharmD Prim Care Companion CNS Disord e1 2015;17(2):doi:10.4088/PCC.14m01717
-
A Common Variant of BDNF Predicts Lack of Response to Intravenous Ketamine
-
Transgenerational Transmission of PTSD From Parents to Children
Advanced Psychiatry Certifications